| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)
|
Lin, H.-M.
|
|
|
36 |
9 |
p. 1068-1077
|
artikel
|
| 2 |
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis ☆
|
Hoffman-Censits, J.
|
|
|
36 |
9 |
p. 1088-1095
|
artikel
|
| 3 |
Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting
|
Belcaid, L.
|
|
|
36 |
9 |
p. 1078-1087
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
36 |
9 |
p. iii
|
artikel
|
| 5 |
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial
|
Tombal, B.
|
|
|
36 |
9 |
p. 1058-1067
|
artikel
|
| 6 |
Imatinib’s last lessons? A roadmap to cure
|
Napolitano, A.
|
|
|
36 |
9 |
p. 1005-1006
|
artikel
|
| 7 |
Letter to the editor ‘A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases’ by F. André et al.
|
Liu, Y.
|
|
|
36 |
9 |
p. 1107
|
artikel
|
| 8 |
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
|
Hofheinz, R.-D.
|
|
|
36 |
9 |
p. 1007-1024
|
artikel
|
| 9 |
Long-term development after maternal cancer treatment: some reassurance but still open questions
|
Loibl, S.
|
|
|
36 |
9 |
p. 1003-1004
|
artikel
|
| 10 |
Long-term development of 12- and 15-year-old offspring after maternal cancer diagnosis during pregnancy: a prospective multicentre cohort study
|
Huis in ’t Veld, E.A.
|
|
|
36 |
9 |
p. 1025-1034
|
artikel
|
| 11 |
Reply to Letter to the Editor: ‘A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases’ by Y. Liu & C. Zhang
|
André, F.
|
|
|
36 |
9 |
p. 1108
|
artikel
|
| 12 |
Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancer
|
Sentís, I.
|
|
|
36 |
9 |
p. 1096-1106
|
artikel
|
| 13 |
Table of Contents
|
|
|
|
36 |
9 |
p. i-ii
|
artikel
|
| 14 |
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial
|
Blay, J.-Y.
|
|
|
36 |
9 |
p. 1035-1046
|
artikel
|
| 15 |
Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses
|
Mayadev, J.
|
|
|
36 |
9 |
p. 1047-1057
|
artikel
|
Tijdschrift beschrijving